[1]
|
WADA, “The world Anti-Doping Code—the 2009 Prohibited List: International Standard,” World Anti-Doping Agency, Montreal, 2009.
|
[2]
|
WADA, “Minimum Required Performance Limits for Detection of Prohibited Substances (Technical Document TD2009MRPL),” World Anti-Doping Agency, Montreal, 2009.
|
[3]
|
R. Ventura and J. Segura, “Detection of Diuretic Agents in Doping Control,” Journal of Chromatography B, Vol. 687, No. 1, 1996, pp. 127-144.
doi:10.1016/S0378-4347(96)00279-4
|
[4]
|
M. Mazzarino, X. de la Torre and F. Botrè, “A Screening Method for the Simultaneous Detection of Glucocorti-coids, Diuretics, Stimulants, Anti-Estrogens, Beta-Adrenergic Drugs and Anabolic Steroids in Human Urine by LC-ESI-MS/MS,” Analytical and Bioanalytical Chemistry, Vol. 392, No. 4, 2008, pp. 681-698.
doi:10.1007/s00216-008-2292-5
|
[5]
|
O. J. Pozo, P. Van Eenoo, K. Deventer and F. T. Delbeke, “Development and Validation of a Qualitative Screening Method for the Detection of Exogenous Anabolic Steroids in Urine by liquid Chromatography-Tandem Mass Spectrometry,” Analytical and Bioanalytical Chemistry, Vol. 389, No. 4, 2007, pp. 1209-1224.
doi:10.1007/s00216-007-1530-6
|
[6]
|
K. Deventer, O. J. Pozo, P. Van Eenoo and F. T. Delbeke, “Qualitative Detection of Diuretics and Acidic Metabolites of Other Doping Agents in Human Urine by High-Performance Liquid Chromatography-Tandem Mass Spectrometry. Comparison between Liquid-Liquid Extraction and Direct Injection,” Journal of Chromatography A, Vol. 1216, No. 31, 2009, pp. 5819-5827.
doi:10.1016/j.chroma.2009.06.003
|
[7]
|
R. Ventura, M. Roig, N. Monfort, P. Saez, R. Berges and J. Segura, “High-Throughput and Sensitive Screening by Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry of Diuretics and Other Doping Agents,” European Journal of Mass Spectrometry, Vol. 14, No. 3, 2008, pp. 191-200. doi:10.1255/ejms.920
|
[8]
|
V. Morra, P. Davit and P. Capra, “Fast Gas Chromatographic/Mass Spectrometric Determination of Diuretics and Masking Agents in Human Urine. Development and Validation of a Productive Screening Protocol for Anti-doping Analysis,” Journal of Chromatography A, Vol. 1135, No. 2, 2006, pp. 219-229.
doi:10.1016/j.chroma.2006.09.034
|
[9]
|
L. Amendola, C. Colamonici, M. Mazzarino and F. Botrè, “Rapid Determination of Diuretics in Human Urine by Gas Chromatography-Mass Spectrometry Following Micro- wave Assisted Derivatization,” Analytica Chimica Acta, Vol. 475, No. 1-2, 2003, pp. 125-136.
doi:10.1016/S0003-2670(02)01223-0
|
[10]
|
C. Brunelli, C. Bicchi, A. Di Stilo, A. Salomone and M. Vincenti, “High-Speed Gas Chromatography in Doping Control: Fast-GC and Fast-GC/MS Determination of β- Adrenoceptor Ligands and Diuretics,” Journal of Separation Science, Vol. 29, No. 18, 2006, pp. 2765-2771.
doi:10.1002/jssc.200500387
|
[11]
|
Y.-L. Tseng, M.-H. Shieh, C.-T. Lin and F.-H. Kuo, “Detection of Diuretics in Urine during Sports Events in Taiwan,” Tzu Chi Medical Journal, Vol. 16, No. 2, 2004, pp. 69-77.
|
[12]
|
P. Van Eenoo and F. T. Delbeke, “Criteria in Chromatography and Mass-Spectrometry—A Comparison between Regulations in the Field of Residue and Doping Analysis,” Chromatographia, Vol. 59, Suppl. 1, 2004, pp. 39- 44. doi:10.1365/s10337-004-0198-8
|
[13]
|
L. Politi, L. Morini and A. Polettini, “A Direct Screening Procedure for Diuretics in Human Urine by Liquid Chromatography-Tandem Mass Spectrometry with Information Dependent Acquisition,” Clinica Chimica Acta, Vol. 386, No. 1-2, 2007, pp. 46-52.
doi:10.1016/j.cca.2007.07.018
|
[14]
|
C. Goebel, G. Trout and R. Kazlauskas, “Rapid Screening Method for Diuretics in Doping Control Using Auto-mated Solid Phase Extraction and Liqud Chromatography-Electrospray Tandem Mass Spectrometry,” Analytica Chimica Acta, Vol. 502, No. 1, 2004, pp. 65-74.
doi:10.1016/j.aca.2003.09.062
|
[15]
|
D. Thieme, J. Grosse, R. Lang, R. K. Mueller and A. Wahl, “Screening, Confirmation an Quantification of Diuretics in Urine for Doping Control Analysis by High-Perform- ance Liquid Chromatography-Atmospheric Pressure Ionization Tandem Mass Spectrometry,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 757, No. 1, 2001, pp. 49-57.
doi:10.1016/S0378-4347(01)00058-5
|
[16]
|
S. J. Park, H. S. Pyo, Y. J. Kim, M. S. Kim and J. Park, “Systematic Analysis of Diuretic Doping Agents by HPLC Screening and GC/MS Confirmation,” Journal of Analytical Toxicology, Vol. 14, No. 2, 1990, pp. 84-90.
|
[17]
|
ISO/IEC 17025, “General Requirements for the Competence of Testing and Calibration Laboratories,” 2006.
|
[18]
|
Eurachem Working Group, “A Laboratory Guide to Method Validation and Related Topics,” Eurachem, Teddington, 1998.
|
[19]
|
WADA, “The International Standard for Laboratories, Version 6.0,” World Anti-Doping Agency, Montreal, 2009.
|
[20]
|
E. Hoffmann and V. Stroobant, “Mass Spectrometry. Principles and Applications,” 3rd Edition, WILEY-VCH Ver- lag GmbH & Co. KGaA, Weinheim, 2007.
|
[21]
|
WADA, “Identification Criteria for Qualitative Assays Incorporating Column Chromatography and Mass Spectrometry (Number TD2010IDCR),” World Anti-Doping Agency, Montreal, 2010.
|